Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,292 papers from all fields of science
Search
Sign In
Create Free Account
Histamine Agonists [MoA]
Known as:
Histamine Agonists
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Allergenic extract
Alternaria alternata allergenic extract
Alternaria alternata allergenic extract 0.8 MG/ML Injectable Solution
Histamine Agonists
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
An ab initio study of histamine agonists.
A. Yadav
,
V. Yadav
Indian Journal of Biochemistry & Biophysics
1997
Corpus ID: 6748878
A systematic theoretical study on histamine agonists and their interaction with H1 and H2 receptor models has been carried out…
Expand
1985
1985
Modulation of in vitro cellular immune response by histamine agonists or antagonists in murine species.
S. French
,
M. Walker
,
B. Susskind
,
R. Faanes
Arzneimittel-Forschung
1985
Corpus ID: 44354790
The generation of secondary cytotoxic T-lymphocyte (CTL) responses in vitro toward allogeneic P815 mastocytoma cells were…
Expand
1982
1982
Histamine suppresses in vitro synthesis of precursor (pro-C5) of the fifth complement component (C5) by mouse peritoneal macrophages.
Y. M. Ooi
Journal of Immunology
1982
Corpus ID: 38490417
Soluble histamine added to mouse peritoneal macrophages in culture suppressed the synthesis of the functional and antigenic…
Expand
1981
1981
The effect of theophylline on histamine H1 and H2 receptor mediated responses in rabbit atria.
A. Polanin
,
J. McNeill
Canadian Journal of Physiology and Pharmacology
1981
Corpus ID: 23502330
Rabbit isolated right and left atria were exposed to theophylline and to selected doses of histamine agonists. Right atrial rate…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE